EPharmacy Market By Region- Global Industry Analysis and Forecast to 2023

2018-05-30 / 3800.00 / Pharma & Healthcare / 80 Pages

Description

Industry Outlook and Trend Analysis

The ePharmacy Market was worth USD 25.18 billion in 2014 and is expected to reach approximately USD 86.97 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 14.76% during the forecast period. Expanded penetration of the internet over the world, enhanced medicinal services foundation, rapid aging of the populace, and expanding awareness relating to ecommerce among clients are a portion of the elements driving development. Change in customer conduct with an expanded interest for convenience is additionally one of the key components adding to the market development. Besides, rising adoption of ecommerce based business and advanced innovations in medicinal services part is anticipated to drive development.

Regional Outlook and Trend Analysis

North America commanded the ePharmacy market in 2016 with the biggest share of the overall industry. High adoption of internet business, increment in online requests, and development in elderly populace are a portion of the key factors that add to the substantial share of the market. Existence of entrenched players and increment in pharmaceutical needs, particularly of people born after WW2, are additionally anticipated that would drive development. Asia Pacific is anticipated to enlist speediest development throughout the following couple of years inferable from the existence of an expansive patient pool and ascend in target populace. Developing economies, for example, China and India have a high development potential. Vast populace base of these nations alongside the high neglected medicinal needs are a portion of the difficulties looked by the social insurance area in these districts.

Competitive Insights

The leading players in the market are Rowlands Pharmacy, CVS Health, DocMorris N.V, Giant Eagle, OptumRx Inc, Express Scripts, Kroger, Walmart and Walgreens. These players are embracing different promoting techniques to increase higher share in the ePharmacy market and concentrating on extending their geographic existence, particularly in developing locales that offer lucrative opportunities.

The ePharmacy Market is segmented as follows-

By Region


North America



U.S
Canada
Mexico



Europe



Germany
France
UK
Italy
Spain
Rest of Europe



Asia-Pacific



Japan
China
Australia
India
South Korea
Rest of Asia Pacific



Rest of the World



Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2023`
What will be the industry market growth from 2015 to 2023`
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast`
What are the major segments leading the market growth and why`
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2014-2023)
4.1.2. Canada Market States and Outlook (2014-2023)
4.1.3. Mexico Market States and Outlook (2014-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2014-2023)
4.2.2. France Market States and Outlook (2014-2023)
4.2.3. UK Market States and Outlook (2014-2023)
4.2.4. Russia Market States and Outlook (2014-2023)
4.2.5. Italy Market States and Outlook (2014-2023)
4.2.6. Rest of Europe Market States and Outlook (2014-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2014-2023)
4.3.2. Japan Market States and Outlook (2014-2023)
4.3.3. Korea Market States and Outlook (2014-2023)
4.3.4. India Market States and Outlook (2014-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2014-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2014-2023)
4.4.2. Argentina Market States and Outlook (2014-2023)
4.4.3. Columbia Market States and Outlook (2014-2023)
4.4.4. Rest of South America Market States and Outlook (2014-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2014-2023)
4.5.2. UAE Market States and Outlook (2014-2023)
4.5.3. Egypt Market States and Outlook (2014-2023)
4.5.4. Nigeria Market States and Outlook (2014-2023)
4.5.5. South Africa Market States and Outlook (2014-2023)
4.5.6. Rest of MEA Market States and Outlook (2014-2023)
5. EPharmacy Market, By Region
5.1. Introduction
5.2. Global EPharmacy Sales, Revenue and Market Share by Regions
5.2.1. Global EPharmacy Sales by Regions (2014-2018)
5.2.2. Global EPharmacy Revenue by Regions (2014-2018)
5.3. North America EPharmacy by Countries
5.3.1. North America EPharmacy Sales and Growth Rate (2014-2018)
5.3.2. North America EPharmacy Revenue and Growth Rate (2014-2018)
5.3.3. North America EPharmacy Sales by Countries (2014-2018)
5.3.4. North America EPharmacy Revenue (Million USD) by Countries (2014-2018)
5.3.5. U.S.
5.3.5.1. United States EPharmacy Sales and Growth Rate (2014-2018)
5.3.5.2. United States EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.3.6. Canada
5.3.6.1. Canada EPharmacy Sales and Growth Rate (2014-2018)
5.3.6.2. Canada EPharmacy Sales (Millions USD) and Growth Rate (2014-2018)
5.3.7. Mexico
5.3.7.1. Mexico EPharmacy Sales and Growth Rate (2014-2018)
5.3.7.2. Mexico EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.4. Europe EPharmacy by Countries
5.4.1. Europe EPharmacy Sales and Growth Rate (2014-2018)
5.4.2. Europe EPharmacy Revenue and Growth Rate (2014-2018)
5.4.3. Europe EPharmacy Sales by Countries (2014-2018)
5.4.4. Europe EPharmacy Revenue (Million USD) by Countries (2014-2018)
5.4.5. Germany
5.4.5.1. Germany EPharmacy Sales and Growth Rate (2014-2018)
5.4.5.2. Germany EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.4.6. UK
5.4.6.1. UK EPharmacy Sales and Growth Rate (2014-2018)
5.4.6.2. UK EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.4.7. France
5.4.7.1. France EPharmacy Sales and Growth Rate (2014-2018)
5.4.7.2. France EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.4.8. Russia
5.4.8.1. Russia EPharmacy Sales and Growth Rate (2014-2018)
5.4.8.2. Russia EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.4.9. Italy
5.4.9.1. Italy EPharmacy Sales and Growth Rate (2014-2018)
5.4.9.2. Italy EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.4.10. Rest of Europe
5.4.10.1. Rest of Europe EPharmacy Sales and Growth Rate (2014-2018)
5.4.10.2. Rest of Europe EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.5. Asia-Pacific
5.5.1. Asia-Pacific EPharmacy Sales and Growth Rate (2014-2018)
5.5.2. Asia-Pacific EPharmacy Revenue and Growth Rate (2014-2018)
5.5.3. Asia-Pacific EPharmacy Sales by Countries (2014-2018)
5.5.4. Asia-Pacific EPharmacy Revenue (Million USD) by Countries (2014-2018)
5.5.5. China
5.5.5.1. China EPharmacy Sales and Growth Rate (2014-2018)
5.5.5.2. China EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.5.6. Japan
5.5.6.1. Japan EPharmacy Sales and Growth Rate (2014-2018)
5.5.6.2. Japan EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.5.6.3.
5.5.7. Korea
5.5.7.1. Korea EPharmacy Sales and Growth Rate (2014-2018)
5.5.7.2. Korea EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.5.8. India
5.5.8.1. India EPharmacy Sales and Growth Rate (2014-2018)
5.5.8.2. India EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.5.9. Southeast Asia
5.5.9.1. Southeast Asia EPharmacy Sales and Growth Rate (2014-2018)
5.5.9.2. Southeast Asia EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.5.10. Rest of Asia-Pacific
5.5.10.1. Rest of Asia-Pacific EPharmacy Sales and Growth Rate (2014-2018)
5.5.10.2. Rest of Asia-Pacific EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.6. South America
5.6.1. South America EPharmacy Sales and Growth Rate (2014-2018)
5.6.2. South America EPharmacy Revenue and Growth Rate (2014-2018)
5.6.3. South America EPharmacy Sales by Countries (2014-2018)
5.6.4. South America EPharmacy Revenue (Million USD) by Countries (2014-2018)
5.6.5. Brazil
5.6.5.1. Brazil EPharmacy Sales and Growth Rate (2014-2018)
5.6.5.2. Brazil EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.6.6. Argentina
5.6.6.1. Argentina EPharmacy Sales and Growth Rate (2014-2018)
5.6.6.2. Argentina EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.6.7. Columbia
5.6.7.1. Columbia EPharmacy Sales and Growth Rate (2014-2018)
5.6.7.2. Columbia EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.6.8. Rest of South America
5.6.8.1. Rest of South America EPharmacy Sales and Growth Rate (2014-2018)
5.6.8.2. Rest of South America EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.7. Middle East and Africa
5.7.1. Middle East and Africa EPharmacy Sales and Growth Rate (2014-2018)
5.7.2. Middle East and Africa EPharmacy Revenue and Growth Rate (2014-2018)
5.7.3. Middle East and Africa EPharmacy Sales by Countries (2014-2018)
5.7.4. Middle East and Africa EPharmacy Revenue (Million USD) by Countries (2014-2018)
5.7.5. Saudi Arabia
5.7.5.1. Saudi Arabia EPharmacy Sales and Growth Rate (2014-2018)
5.7.5.2. Saudi Arabia EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.7.6. United Arab Emirates
5.7.6.1. United Arab Emirates EPharmacy Sales and Growth Rate (2014-2018)
5.7.6.2. United Arab Emirates EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.7.7. Egypt
5.7.7.1. Egypt EPharmacy Sales and Growth Rate (2014-2018)
5.7.7.2. Egypt EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.7.8. Nigeria
5.7.8.1. Nigeria EPharmacy Sales and Growth Rate (2014-2018)
5.7.8.2. Nigeria EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.7.9. South Africa
5.7.9.1. South Africa EPharmacy Sales and Growth Rate (2014-2018)
5.7.9.2. South Africa EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
5.7.10. Rest of Middle East and Africa
5.7.10.1. Rest of Middle East and Africa EPharmacy Sales and Growth Rate (2014-2018)
5.7.10.2. Rest of Middle East and Africa EPharmacy Revenue (Millions USD) and Growth Rate (2014-2018)
6. Company Profiles
6.1. The Kroger Co.
6.1.1. Business Overview
6.1.2. Product Portfolio
6.1.3. Strategic Developments
6.1.4. Sales, Revenue and Market Share
6.2. Walgreen Co.
6.2.1. Business Overview
6.2.2. Product Portfolio
6.2.3. Strategic Developments
6.2.4. Sales, Revenue and Market Share
6.3. Giant Eagle, Inc.
6.3.1. Business Overview
6.3.2. Product Portfolio
6.3.3. Strategic Developments
6.3.4. Sales, Revenue and Market Share
6.4. Walmart Stores, Inc.
6.4.1. Business Overview
6.4.2. Product Portfolio
6.4.3. Strategic Developments
6.4.4. Sales, Revenue and Market Share
6.5. Express Scripts Holding Company
6.5.1. Business Overview
6.5.2. Product Portfolio
6.5.3. Strategic Developments
6.5.4. Sales, Revenue and Market Share
6.6. CVS Health
6.6.1. Business Overview
6.6.2. Product Portfolio
6.6.3. Strategic Developments
6.6.4. Sales, Revenue and Market Share
6.7. Optum Rx, Inc.
6.7.1. Business Overview
6.7.2. Product Portfolio
6.7.3. Strategic Developments
6.7.4. Sales, Revenue and Market Share
6.8. Rowlands Pharmacy
6.8.1. Business Overview
6.8.2. Product Portfolio
6.8.3. Strategic Developments
6.8.4. Sales, Revenue and Market Share
6.9. DocMorris (Zur Rose Group AG)
6.9.1. Business Overview
6.9.2. Product Portfolio
6.9.3. Strategic Developments
6.9.4. Sales, Revenue and Market Share
7. Global EPharmacy Market Competition, by Manufacturer
7.1. Global EPharmacy Sales and Market Share by Manufacturer (2016-2017)
7.2. Global EPharmacy Revenue and Market Share by Manufacturer (2016-2017)
7.3. Global EPharmacy Price by Manufacturer (2016-2017)
7.4. Top 5 EPharmacy Manufacturer Market Share
7.5. Market Competition Trend
8. EPharmacy Market Forecast (2018-2023)
8.1. Global EPharmacy Sales, Revenue (Millions USD) and Growth Rate (2018-2023)
8.2. EPharmacy Market Forecast by Regions (2018-2023)
8.2.1. North America EPharmacy Market Forecast (2018-2023)
8.2.1.1. United States EPharmacy Market Forecast (2018-2023)
8.2.1.2. Canada EPharmacy Market Forecast (2018-2023)
8.2.1.3. Mexico EPharmacy Market Forecast (2018-2023)
8.2.2. Europe EPharmacy Market Forecast (2018-2023)
8.2.2.1. Germany EPharmacy Market Forecast (2018-2023)
8.2.2.2. United Kingdom EPharmacy Market Forecast (2018-2023)
8.2.2.3. France EPharmacy Market Forecast (2018-2023)
8.2.2.4. Russia EPharmacy Market Forecast (2018-2023)
8.2.2.5. Italy EPharmacy Market Forecast (2018-2023)
8.2.2.6. Rest of the Europe EPharmacy Market Forecast (2018-2023)
8.2.3. Asia-Pacific EPharmacy Market Forecast (2018-2023)
8.2.3.1. China EPharmacy Market Forecast (2018-2023)
8.2.3.2. Japan EPharmacy Market Forecast (2018-2023)
8.2.3.3. Korea EPharmacy Market Forecast (2018-2023)
8.2.3.4. India EPharmacy Market Forecast (2018-2023)
8.2.3.5. Southeast Asia EPharmacy Market Forecast (2018-2023)
8.2.3.6. Rest of Asia-Pacific EPharmacy Market Forecast (2018-2023)
8.2.4. South America EPharmacy Market Forecast (2018-2023)
8.2.4.1. Brazil EPharmacy Market Forecast (2018-2023)
8.2.4.2. Argentina EPharmacy Market Forecast (2018-2023)
8.2.4.3. Columbia EPharmacy Market Forecast (2018-2023)
8.2.4.4. Rest of South America EPharmacy Market Forecast (2018-2023)
8.2.5. Middle East and Africa EPharmacy Market Forecast (2018-2023)
8.2.5.1. Saudi Arabia EPharmacy Market Forecast (2018-2023)
8.2.5.2. UAE EPharmacy Market Forecast (2018-2023)
8.2.5.3. Egypt EPharmacy Market Forecast (2018-2023)
8.2.5.4. Nigeria EPharmacy Market Forecast (2018-2023)
8.2.5.5. South Africa EPharmacy Market Forecast (2018-2023)
8.2.5.6. Rest of MEA EPharmacy Market Forecast (2018-2023)


Table of Figures

*You can glance through the list of Tables and Figures when you view the sample copy of EPharmacy Market.

Request Sample

* mark fields are compulsory